Participation of the Fas and Fas ligand systems in apoptosis during atrophy of the rat submandibular glands

International Journal of Experimental Pathology

Volumn 88, Issue 1, 2007, Pages 9-17

  Takahashi, Shigeru ^a   Gobe, Glenda C ^b   Yoshimura, Yoshitaka ^a   Kohgo, Takao ^a   Yamamoto, Tsuneyuki ^a   Wakita, Minoru ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Apoptosis; Atrophy; Fas; Fas ligand; Submandibular gland

Indexed keywords

CASPASE 3; CASPASE 8; FAS ANTIGEN; FAS LIGAND;

ACINAR CELL; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATROPHY; CELL COUNT; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LIGATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBMANDIBULAR GLAND; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; ATROPHY; BIOLOGICAL MARKERS; CASPASE 3; CASPASE 8; ENZYME ACTIVATION; FAS LIGAND PROTEIN; IMMUNOHISTOCHEMISTRY; MALE; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, WISTAR; SUBMANDIBULAR GLAND;

EID: 33846440147     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2006.00511.x     Document Type: Article

References (38)

1. Barnhart B.C., Alappat E.C., Peter M.E. (2003) The CD95 Type I/Type II model. Semin. Immunol. 15, 185-193.
2. Bellgrau D., Gold D., Selawry H., Moore J., Franzusoff A., Duke R.C. (1995) A role for CD95 ligand in preventing graft rejection. Nature 377, 630-632.
3. Cummins M., Dardick I., Burford-Mason A. (1994) Obstructive sialadenitis: a rat model. J. Otolaryngol. 23, 50-56.
4. Curtin J.F. & Cotter T.G. (2003) Live and let die: regulatory mechanisms in Fas-mediated apoptosis. Cell Signal 15, 983-992.
5. Galle P.R., Hofmann W.J., Walczak H. et al. (1995) Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182, 1223-1230.
6. Griffith T.S., Brunner T., Fletcher S.M., Green D.R., Ferguson T.A. (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270, 1189-1192.
7. Hakuno N., Koji T., Yano T. et al. (1996) Fas/APO-1/CD 95 system as a mediator of granulosa cell apoptosis in ovarian follicle atresia. Endocrinology 137, 1938-1948.
8. Harrison J.D. & Garrett J.R. (1972) Mucocele formation in cats by glandular duct ligation. Arch. Oral Biol. 17, 1403-1414.
9. Harrison J.D., Fouad H.M.A., Garrett J.R. (2001) Variation in the response to ductal obstruction of feline submandibular and sublingual salivary glands and the importance of the innervation. J. Oral Pathol. Med. 30, 29-34.
10. Hasel C., Rau B., Perner S., Sträter J., Möller P. (2001) Differential and mutually exclusive expression of CD95 and CD 95 ligand in epithelia of normal pancreas and chronic pancreatitis. Lab. Invest. 81, 317-326.
11. Hayashi Y., Arakaki R., Ishimaru N. (2003) The role of caspase cascade on the development of primary Sjögren's syndrome. J. Med. Invest. 50, 32-38.
12. Hua F., Cornejo M.G., Cardone M.H., Stokes C.L., Lauffenburger D.A. (2005) Effect of bcl-2 levels on Fas signaling-induced caspase-3 activation: molecular genetic tests of computational model predictions. J. Immunol. 175, 985-995.
13. Kayagaki N., Kawasaki A., Ebata T. et al. (1995) Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med. 182, 1777-1783.
14. Kong L., Ogawa N., Nakabayashi T. et al. (1997) Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. Arthr. Rheum. 40, 87-97.
15. Kornmann M., Ishiwata T., Maruyama H., Beger H.G., Korc M. (2000) Coexpression of Fas and Fas-ligand in chronic pancreatitis: correlation with apoptosis. Pancreas 20, 123-128.
16. Maher S., Toomey D., Condron C., Bouchier-Hayes D. (2002) Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack. Immunol. Cell Biol. 80, 131-137.
17. Manganelli P. & Fietta P. (2003) Apoptosis and Sjögren syndrome. Semin. Arthr. Rheum. 33, 49-65.
18. Matsumura R., Umemiya K., Kagami M. et al. (1998) Glandular and extraglandular expression of the Fas-Fas ligand and apoptosis in patients with Sjögren's syndrome. Clin. Exp. Rheumatol. 16, 561-568.
19. Matthews T.W. & Dardick I. (1988) Morphological alterations of salivary gland parenchyma in chronic sialadenitis. J. Otolaryngol. 17, 385-398.
20. McIlroy D., Sakahira H., Talanian R.V., Nagata S. (1999) Involvement of caspase 3-activated DNase in internucleosomal DNA cleavage induced by diverse apoptotic stimuli. Oncogene 18, 4401-4408.
21. Nagata S. (1999) Fas ligand-induced apoptosis. Annu. Rev. Genet. 33, 29-55.
22. Ohlsson M., Skarstein K., Bolstad A.J., Johannessen A.C., Johnsson R. (2001) Fas-induced apoptosis is a rare event in Sjögren's syndrome. Lab. Invest. 81, 95-105.
23. Saito I., Haruta K., Shimuta M. et al. (1999) Fas ligand-mediated exocrinopathy resembling Sjögren's syndrome in mice transgenic for IL-10. J. Immunol. 162, 2488-2494.
24. Sakahira H., Enari M., Nagata S. (1998) Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391, 96-99.
25. Scaffidi C., Fulda S., Srinivasan A. et al. (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17, 1675-1687.
26. Schelling J.R., Nkemere N., Kopp J.B., Cleveland R.P. (1998) Fas-dependent fratricidal apoptosis is a mechanism of tubular epithelial cell deletion in chronic renal failure. Lab. Invest. 78, 813-824.
27. Shibata Y., Hishikawa Y., Izumi S., Fujita S., Yamaguchi A., Koji T. (2002) Involvement of Fas/Fas ligand in the induction of apoptosis in chronic sialadenitis of minor salivary glands including Sjögren's syndrome. Hum. Cell 15, 52-60.
28. Stennicke H.R., Jürgensmeier J.M., Shin H. et al. (1998) Pro - caspase-3 is a major physiological target of caspase-8. J. Biol. Chem. 273, 27084-27090.
29. Suda T. & Nagata S. (1994) Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179, 873-879.
30. Suda T., Takahashi T., Goldstein P., Nagata S. (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75, 1169-1178.
31. Takada T., Nishida K., Doita M., Kurosaka M. (2002) Fas ligand exists on intervertebral disc cells: a potential molecular mechanism for immune privilege of the disc. Spine 27, 1526-1530.
32. Takahashi S., Nakamura S., Suzuki R. et al. (2000) Apoptosis and mitosis of parenchymal cells in the duct-ligated rat submandibular gland. Tissue Cell 32, 457-463.
33. Takahashi S., Shinzato K., Nakamura S., Domon T., Yamamoto T., Wakita M. (2002) The roles of apoptosis and mitosis in atrophy of the rat sublingual gland. Tissue Cell 34, 297-304.
34. Tanaka M., Suda T., Takahashi T., Nagata S. (1995) Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14, 1129-1135.
35. Thompson C.B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462.
36. Walker N.I. & Gobe G.C. (1987) Cell death and cell proliferation during atrophy of the rat parotid gland induced by duct obstruction. J. Pathol. 153, 333-344.
37. Watanabe-Fukunaga R., Brannan C.I., Itoh N. et al. (1992) The cDNA structure expression and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148, 1274-1279.
38. Yasuda H., Kataoka K., Ichimura H. et al. (1999) Cytokine expression and induction of acinar cell apoptosis after pancreatic duct ligation in mice. J. Interferon Cytokine Res. 19, 637-644.